Asthma relating compound 1
Asthma relating compound 1 is an anti-asthmatic agent candidate extracted from patent EP0295656A1.
Product Specifications
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Benzenesulfonamide,_4-[[_6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl_amino]methyl]-.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(CNC2=NC3=C(C)C(C)=C(O)C(C)=C3S2)C=C1)(N)=O
Molecular Formula
C17H19N3O3S2
Molecular Weight
377.48
References & Citations
[1]Abe S, et al. Benzothiazole derivative, its use, and pharmaceutical compositions comprising it. EP0295656A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-U00412/Asthma-relating-compound-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-U00412/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[120165-51-7]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PANK2 Antibody - C-terminal region : FITC (ARP63793_P050-FITC)
